[Bacteraemia in children in Iceland 1994-2005]

Laeknabladid
|July 2, 2008
PubMed

Insights

This study analyzed pediatric blood cultures in Iceland, finding increasing macrolide resistance in common bacteria and confirming the effectiveness of meningococcal C vaccination in children.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Microbiology
  • Epidemiology

Background:

  • Positive blood cultures in children often indicate serious bloodstream infections requiring prompt, age-appropriate treatment.
  • Accurate data on bacterial prevalence and antibiotic susceptibility are crucial for guiding empirical antibiotic therapy and vaccination strategies.

Purpose of the Study:

  • To investigate epidemiological parameters of positive bacterial blood cultures in Icelandic children aged 0-18 years.
  • To inform empirical antibiotic treatment and vaccination programs based on local resistance patterns and pathogen prevalence.

Main Methods:

  • Retrospective analysis of all positive bacterial blood cultures from children (0-18 years) at Landspitali University Hospital (1994-2005).
  • Data collected included patient age, sex, bacterial etiology, collection date, and antimicrobial susceptibility.
  • Children were categorized into four age groups: neonates, infants, preschool, and school-aged.

Main Results:

  • 1253 positive blood cultures from 974 children were analyzed; 47.4% were from children under one year old.
  • Coagulase-negative staphylococci were most common (37%). Among definite infections, Streptococcus pneumoniae (21.7%), Staphylococcus aureus (19.8%), and Neisseria meningitidis (15.2%) predominated.
  • Macrolide resistance was high in pneumococci (19%) and group A streptococci (33%). No N. meningitidis serogroup C was isolated post-vaccination launch in 2002.

Conclusions:

  • Findings provide essential data for empirical antibiotic therapy and vaccination strategies in Icelandic children.
  • Rising macrolide resistance reduces the effectiveness of these antibiotics for empiric treatment of pediatric sepsis.
  • Meningococcal C vaccination demonstrated high efficacy; results aid in predicting pneumococcal vaccine effectiveness.
Abstract

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...